Global Multiple Myeloma Drugs Market Research Report 2016

December 2016 | 110 pages | ID: G33FB69834CEN
QYResearch

Abstracts

Notes:

Production, means the output of Multiple Myeloma Drugs

Revenue, means the sales value of Multiple Myeloma Drugs

This report studies Multiple Myeloma Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Amgen
• Johnson & Johnson
• Celgene
• Takeda Pharmaceutical
• Novartis
• Daiichi Sankyo
• Merck
• AB Science
• Teva
• PharmaMar
• Bristol Myers Squibb

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Multiple Myeloma Drugs in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Immunomodulatory drugs (IMiDs)
• Proteasome inhibitors
• Chemotherapy
• Histone deacetylase inhibitor (HDAC inhibitor)
• Steroids (corticosteroids)

Split by application, this report focuses on consumption, market share and growth rate of Multiple Myeloma Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Multiple Myeloma Drugs Market Research Report 2016

1 MULTIPLE MYELOMA DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Multiple Myeloma Drugs
1.2 Multiple Myeloma Drugs Segment by Type
  1.2.1 Global Production Market Share of Multiple Myeloma Drugs by Type in 2015
  1.2.2 Immunomodulatory drugs (IMiDs)
  1.2.3 Proteasome inhibitors
  1.2.4 Chemotherapy
  1.2.5 Histone deacetylase inhibitor (HDAC inhibitor)
  1.2.6 Steroids (corticosteroids)
1.3 Multiple Myeloma Drugs Segment by Application
  1.3.1 Multiple Myeloma Drugs Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Multiple Myeloma Drugs Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Multiple Myeloma Drugs (2011-2021)

2 GLOBAL MULTIPLE MYELOMA DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Multiple Myeloma Drugs Production and Share by Manufacturers (2015 and 2016)
2.2 Global Multiple Myeloma Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Multiple Myeloma Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Multiple Myeloma Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Multiple Myeloma Drugs Market Competitive Situation and Trends
  2.5.1 Multiple Myeloma Drugs Market Concentration Rate
  2.5.2 Multiple Myeloma Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL MULTIPLE MYELOMA DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Multiple Myeloma Drugs Production and Market Share by Region (2011-2016)
3.2 Global Multiple Myeloma Drugs Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL MULTIPLE MYELOMA DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Multiple Myeloma Drugs Consumption by Regions (2011-2016)
4.2 North America Multiple Myeloma Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Multiple Myeloma Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Multiple Myeloma Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Multiple Myeloma Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Multiple Myeloma Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Multiple Myeloma Drugs Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL MULTIPLE MYELOMA DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Multiple Myeloma Drugs Production and Market Share by Type (2011-2016)
5.2 Global Multiple Myeloma Drugs Revenue and Market Share by Type (2011-2016)
5.3 Global Multiple Myeloma Drugs Price by Type (2011-2016)
5.4 Global Multiple Myeloma Drugs Production Growth by Type (2011-2016)

6 GLOBAL MULTIPLE MYELOMA DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Multiple Myeloma Drugs Consumption and Market Share by Application (2011-2016)
6.2 Global Multiple Myeloma Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL MULTIPLE MYELOMA DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Amgen
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Multiple Myeloma Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Amgen Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Johnson & Johnson
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Multiple Myeloma Drugs Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Johnson & Johnson Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Celgene
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Multiple Myeloma Drugs Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Celgene Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Takeda Pharmaceutical
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Multiple Myeloma Drugs Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Takeda Pharmaceutical Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Novartis
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Multiple Myeloma Drugs Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Novartis Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Daiichi Sankyo
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Multiple Myeloma Drugs Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Daiichi Sankyo Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Merck
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Multiple Myeloma Drugs Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Merck Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 AB Science
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Multiple Myeloma Drugs Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 AB Science Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Teva
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Multiple Myeloma Drugs Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Teva Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 PharmaMar
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Multiple Myeloma Drugs Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 PharmaMar Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Bristol Myers Squibb

8 MULTIPLE MYELOMA DRUGS MANUFACTURING COST ANALYSIS

8.1 Multiple Myeloma Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Multiple Myeloma Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Multiple Myeloma Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Multiple Myeloma Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL MULTIPLE MYELOMA DRUGS MARKET FORECAST (2016-2021)

12.1 Global Multiple Myeloma Drugs Production, Revenue Forecast (2016-2021)
12.2 Global Multiple Myeloma Drugs Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Multiple Myeloma Drugs Production Forecast by Type (2016-2021)
12.4 Global Multiple Myeloma Drugs Consumption Forecast by Application (2016-2021)
12.5 Multiple Myeloma Drugs Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Multiple Myeloma Drugs
Figure Global Production Market Share of Multiple Myeloma Drugs by Type in 2015
Figure Product Picture of Immunomodulatory drugs (IMiDs)
Table Major Manufacturers of Immunomodulatory drugs (IMiDs)
Figure Product Picture of Proteasome inhibitors
Table Major Manufacturers of Proteasome inhibitors
Figure Product Picture of Chemotherapy
Table Major Manufacturers of Chemotherapy
Figure Product Picture of Histone deacetylase inhibitor (HDAC inhibitor)
Table Major Manufacturers of Histone deacetylase inhibitor (HDAC inhibitor)
Figure Product Picture of Steroids (corticosteroids)
Table Major Manufacturers of Steroids (corticosteroids)
Table Multiple Myeloma Drugs Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Multiple Myeloma Drugs Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Multiple Myeloma Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Multiple Myeloma Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Multiple Myeloma Drugs Production Share by Manufacturers
Figure 2016 Multiple Myeloma Drugs Production Share by Manufacturers
Table Global Multiple Myeloma Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Multiple Myeloma Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Multiple Myeloma Drugs Revenue Share by Manufacturers
Table 2016 Global Multiple Myeloma Drugs Revenue Share by Manufacturers
Table Global Market Multiple Myeloma Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Multiple Myeloma Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Multiple Myeloma Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Multiple Myeloma Drugs Product Type
Figure Multiple Myeloma Drugs Market Share of Top 3 Manufacturers
Figure Multiple Myeloma Drugs Market Share of Top 5 Manufacturers
Table Global Multiple Myeloma Drugs Production by Regions (2011-2016)
Figure Global Multiple Myeloma Drugs Production and Market Share by Regions (2011-2016)
Figure Global Multiple Myeloma Drugs Production Market Share by Regions (2011-2016)
Figure 2015 Global Multiple Myeloma Drugs Production Market Share by Regions
Table Global Multiple Myeloma Drugs Revenue by Regions (2011-2016)
Table Global Multiple Myeloma Drugs Revenue Market Share by Regions (2011-2016)
Table 2015 Global Multiple Myeloma Drugs Revenue Market Share by Regions
Table Global Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table China Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table India Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Multiple Myeloma Drugs Consumption Market by Regions (2011-2016)
Table Global Multiple Myeloma Drugs Consumption Market Share by Regions (2011-2016)
Figure Global Multiple Myeloma Drugs Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Multiple Myeloma Drugs Consumption Market Share by Regions
Table North America Multiple Myeloma Drugs Production, Consumption, Import & Export (2011-2016)
Table Europe Multiple Myeloma Drugs Production, Consumption, Import & Export (2011-2016)
Table China Multiple Myeloma Drugs Production, Consumption, Import & Export (2011-2016)
Table Japan Multiple Myeloma Drugs Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Multiple Myeloma Drugs Production, Consumption, Import & Export (2011-2016)
Table India Multiple Myeloma Drugs Production, Consumption, Import & Export (2011-2016)
Table Global Multiple Myeloma Drugs Production by Type (2011-2016)
Table Global Multiple Myeloma Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Multiple Myeloma Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Multiple Myeloma Drugs by Type
Table Global Multiple Myeloma Drugs Revenue by Type (2011-2016)
Table Global Multiple Myeloma Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Multiple Myeloma Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Multiple Myeloma Drugs by Type
Table Global Multiple Myeloma Drugs Price by Type (2011-2016)
Figure Global Multiple Myeloma Drugs Production Growth by Type (2011-2016)
Table Global Multiple Myeloma Drugs Consumption by Application (2011-2016)
Table Global Multiple Myeloma Drugs Consumption Market Share by Application (2011-2016)
Figure Global Multiple Myeloma Drugs Consumption Market Share by Application in 2015
Table Global Multiple Myeloma Drugs Consumption Growth Rate by Application (2011-2016)
Figure Global Multiple Myeloma Drugs Consumption Growth Rate by Application (2011-2016)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Multiple Myeloma Drugs Market Share (2011-2016)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Multiple Myeloma Drugs Market Share (2011-2016)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Celgene Multiple Myeloma Drugs Market Share (2011-2016)
Table Takeda Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceutical Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Pharmaceutical Multiple Myeloma Drugs Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Multiple Myeloma Drugs Market Share (2011-2016)
Table Daiichi Sankyo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Daiichi Sankyo Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Daiichi Sankyo Multiple Myeloma Drugs Market Share (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Multiple Myeloma Drugs Market Share (2011-2016)
Table AB Science Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AB Science Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure AB Science Multiple Myeloma Drugs Market Share (2011-2016)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Multiple Myeloma Drugs Market Share (2011-2016)
Table PharmaMar Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table PharmaMar Multiple Myeloma Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure PharmaMar Multiple Myeloma Drugs Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Multiple Myeloma Drugs
Figure Manufacturing Process Analysis of Multiple Myeloma Drugs
Figure Multiple Myeloma Drugs Industrial Chain Analysis
Table Raw Materials Sources of Multiple Myeloma Drugs Major Manufacturers in 2015
Table Major Buyers of Multiple Myeloma Drugs
Table Distributors/Traders List
Figure Global Multiple Myeloma Drugs Production and Growth Rate Forecast (2016-2021)
Figure Global Multiple Myeloma Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Multiple Myeloma Drugs Production Forecast by Regions (2016-2021)
Table Global Multiple Myeloma Drugs Consumption Forecast by Regions (2016-2021)
Table Global Multiple Myeloma Drugs Production Forecast by Type (2016-2021)
Table Global Multiple Myeloma Drugs Consumption Forecast by Application (2016-2021)